Pfizer sizes up Russia for opportunities; GAO reports 'lessons' from 2009 pandemic response;

> Pfizer and Russian investor/R&D group ChemRar will explore a collaboration focused on drug research, development and commercialization drugs in Russia and other countries. Article

> A GAO report provides "yet another review of lessons" from the government's response to the H1N1 influenza pandemic, including ongoing spending of the $6.15 billion appropriated. Story

> Delaware is part of a 38-state settlement with GlaxoSmithKline that resolves allegations of substandard manufacturing processes. Article

> PharmAthene says it has achieved a tech milestone in its recombinant anthrax vaccine program: initial technology transfer at the 100-liter scale of its manufacturing process for SparVax to Diosynth in RTP, NC.  PharmAthene announcement

> Document management solutions for pharmaceutical manufacturers are the object of a partnership between NextDocs and Danish IT consultancy NNIT. NextDocs release

> U.K. healthcare logistics specialist Movianto has expanded its cold chain and narcotics handling facility at its Bedford base. Item

> Hyderabad-based Goose has launched Procon Tracker, a track/trace solution to meet regulatory packaging guidelines and detect counterfeits. Goose release

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.